Santos / Larisa / Piscataway / Hilden / Hercules / Helsinki / Austin / Bradford / New York / Madison / Larissa / St Louis / Roach / Eppendorf / Mix / Indianapolis / Alameda / Paisley / Penzberg / Chatsworth / /
Company
IgG / Life Technologies / Qiagen / Pearson / Amersan Biosciences / SPSS / Swick AG / Bio-Rad / Microsoft / /
Country
Germany / United Kingdom / Greece / / /
Event
Product Issues / FDA Phase / /
Facility
Institute of Biomedical Research / University Hospital of Larissa / University of Thessalia / /
IndustryTerm
non-glycosylated protein product / study protocol / osteoarthritis treatment / treatment of cancer / Online First / /
MedicalCondition
solid tumours / JE / complex disease / arthritis / As osteoarthritis / melanoma / multiple sclerosis / human diseases / renal cell carcinoma / non-neoplastic diseases / bone resorption / cancer / disease / age-related disorder / atherogenesis / carcinogenesis / advanced solid tumors / hematologic malignancies / complex non-Mendelian diseases / osteoarthritis / Bull Cancer / lung cancer / inoperable non-small cell lung cancer / experimentally induced osteoarthritis / /
MedicalTreatment
surgery / gene therapy / hip surgery / knee replacement surgery / /
Organization
University Hospital of Larissa / Medical School / Department of Biology / Institute of Biomedical Research and Technology / Leipzig ND / Department of Orthopaedics / Orthopaedics Department / University of Thessalia / Local Ethical Committee / /
Person
Sharif M. Chondrocyte / Ann Rheum Dis / Scott V / Jong Deok Ahn / /
Position
Fernandez MP / /
Product
cisplatin / penicillin / Balanced Salt / area / H3 / /
1616 EXTENDED REPORT